Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
10,165 total articles
Rajiv A. Tata, a Vice President, General Counsel, and Corporate Secretary at Ducommun Inc., sold 1,612 shares of common stock valued at $233,740 on May 20, 2026. This transaction was specifically required to satisfy obligations under the company's Second Amended and Restated Clawback Policy, which was triggered by revisions to previously issued fin…
StoneX Group's Chief Governance/Legal Officer, Diego Rotsztain, recently sold a total of approximately $3.78 million worth of company stock over May 18 and May 20, 2026. These sales occurred after the officer acquired shares through the exercise of stock options. Separately, the company reported its second quarter financial results for fiscal year …
Michael Stock, Chief Financial Officer of Liberty Energy Inc., executed a planned sale of shares on May 20, 2026. This insider activity takes place while the stock is trading near its 52-week high, following robust financial reporting for Q1 2026 and positive analyst commentary regarding the company's market positioning.
Atara Biotherapeutics CEO AnhCo Nguyen sold a portion of his holdings in the company. This transaction occurred while the firm was advancing its biologics license application for tabelecleucel. The FDA provided guidance suggesting that a single-arm study with historical controls could suffice for safety and efficacy data, and Freedom Broker upgrade…
Atara Biotherapeutics' Chief Accounting Officer, Yanina Grant-Huerta, executed a stock sale valued at $22,036. This transaction occurred as the company's shares have seen declines recently, while simultaneously receiving positive updates regarding the resubmission of its biologics license application for tabelecleucel.
The Chief Executive Officer of KORU Medical Systems, Inc., Linda M. Tharby, recently acquired additional common stock in the company. This insider transaction occurs amid positive recent news regarding the firm's financial performance and technological advancements. Specifically, KRMD reported strong first-quarter revenue figures that surpassed ana…
Axcelis Technologies director Gregory B. Graves sold a total value of $456,697 worth of common stock on May 19, 2026. The transaction occurred against a backdrop of mixed company performance, as ACLS reported first-quarter earnings that missed analyst expectations but maintained its full-year sales guidance.
The Trustee in Trust for Milton Hershey School, a major stakeholder in The Hershey Company (NASDAQ: HSY), executed sales totaling approximately $5.75 million of the company's common stock over three trading days in May 2026. This activity occurs while the market notes the stock's recent performance and ongoing analyst assessments regarding its valu…
Alan Kharsansky, Chief Technology Officer of Satellogic Inc. (NASDAQ:SATL), executed a significant sale of Class A Common Stock on May 14, 2026. The transaction involved exercising stock options and subsequently selling the acquired shares, totaling $727,296. This insider activity occurs against a backdrop of positive operational news for Satellogi…
Director Jeanne Quirk sold a significant block of common stock in Axcelis Technologies (ACLS) on May 19, 2026. This transaction occurs against a backdrop of mixed financial news, including the company missing first-quarter earnings expectations and receiving an Underperform rating from BofA Securities.
A key director's recent sale of shares in Axcelis Technologies occurred against a backdrop of the company reporting first-quarter 2026 results that missed both revenue and earnings forecasts. While the semiconductor equipment maker has shown significant returns over the past year, analysts maintain mixed views on its valuation and future trajectory…
Recent filings detail significant stock transactions by MACOM Technology Solutions Holdings, Inc. (NASDAQ:MTSI) CFO John Kober. Concurrently, the company reported robust financial performance for the second fiscal quarter of 2026, with adjusted earnings per share and revenue both surpassing market expectations. These strong results led Needham to u…
Rifat Kerim Akgonul, the Chief Product Officer at Pegasystems Inc. (NASDAQ:PEGA), completed a direct sale of company stock on May 19, 2026. The transaction involved selling 4,545 shares for a total value of $151,575, with each share priced at $33.35. Following the divestiture, Akgonul's reported direct ownership of Pegasystems common stock stands a…
Joseph D Mansueto, Executive Chairman and a ten percent owner of Morningstar, Inc., recently sold a significant block of company stock. This transaction occurred through pre-planned trading arrangements (Rule 10b5-1). Despite the insider selling, recent corporate developments include major rebranding efforts, strategic divestitures, and partnership…
Kevin P. O’Hara, Executive Vice President at HealthStream Inc., recently sold a block of common shares. This activity occurs against the backdrop of recent robust financial performance for the company in Q1 2026, although market reaction to future guidance introduced some caution despite the strong earnings beat.
Heritage Insurance Holdings director, Paul L. Whiting, executed significant purchases of the company's common stock in May 2026. These actions occurred against a backdrop of an earlier first-quarter earnings shortfall, prompting analysts to monitor internal sentiment and valuation metrics closely for potential inflection points.
David M. Shane, Chief Financial Officer and a director at Binah Capital Group, Inc., purchased shares of the company's common stock on May 19, 2026. This transaction occurred while the stock was trading significantly below current prices, signaling internal activity amidst broader corporate developments for the firm.
A director of Vital Farms, Inc. recently purchased a notable amount of the company's common stock. This insider buying occurs against a backdrop of mixed market signals for the company, including recent positive price movements juxtaposed with a significant earnings per share miss reported in the first quarter of 2026.
A recent SEC filing indicates that James E. Cline, a director at Latham Group, Inc., purchased $242,000 in common stock on May 19, 2026. This activity occurs while the stock is trading significantly below its recent historical levels and following an earnings report that disappointed analyst expectations.
Airbnb director and partial owner Joseph Gebbia executed significant stock sales through a predefined trading plan. Concurrently, the company reported strong first-quarter earnings, with revenues increasing 18% year-over-year. Following these results, multiple analyst firms raised their price targets, citing robust growth in gross booking value and…
The recent sale of JPMorgan Chase general counsel Stacey Friedman't shares signals internal transactions within a major financial institution. Separately, the broader banking sector is undergoing significant adjustments, highlighted by JPMorgan leading a substantial loan sale for Warner Bros Discovery. Furthermore, industry leaders are addressing m…
Subir Dutt, Chief Sales Officer at Xometry, Inc., sold approximately $440,896 worth of the company's Class A Common Stock on May 18, 2026. The sale involved 4,943 shares and occurred despite the stock trading near its 52-week high following a significant one-year gain. Concurrently, Xometry reported robust first quarter earnings that surpassed mark…
Arbor Realty Trust director George Tsunis recently increased his direct holdings of the common stock through open market purchases. This activity coincided with a broader set of corporate developments for Arbor, including its Q1 2026 earnings report, which showed an EPS shortfall but exceeded revenue forecasts, alongside significant asset managemen…
The Chief Human Resources Officer of Chefs’ Warehouse, Inc. (NASDAQ:CHEF), Christina Polychroni, conducted a significant stock sale on May 19, 2026. The transaction involved liquidating shares totaling $356,428. Despite this executive selling activity, the company's stock continues to show strong market performance, evidenced by its trading near it…
Iradimed Corp's CEO, Roger E. Susi, executed indirect sales of company common stock totaling $657,264. These transactions occurred between May 18 and May 19, 2026. Separately, the company announced first-quarter 2026 earnings that surpassed analyst forecasts for both earnings per share and revenue, although the stock saw a subsequent decline in pre…
